ARKG vs SCHF
ARK Genomic Revolution ETF vs Schwab International Equity ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SCHF—
Schwab International Equity ETF
Developed-market equities ex-US.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SCHF |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Holdings data unavailable for ARKG.
SCHF top holdings
Holdings data unavailable for SCHF.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SCHF
SCHF (Schwab International Equity ETF) is Developed-market equities ex-US.